202 related articles for article (PubMed ID: 26113075)
1. Lentiviral vector system for coordinated constitutive and drug controlled tetracycline-regulated gene co-expression.
Stahlhut M; Schwarzer A; Eder M; Yang M; Li Z; Morgan M; Schambach A; Kustikova OS
Biomaterials; 2015 Sep; 63():189-201. PubMed ID: 26113075
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Lentiviral Vectors for Pharmacologically Controlled Switching Between Constitutive Single Gene Expression and Tetracycline-Regulated Multiple Gene Collaboration.
Stahlhut M; Schambach A; Kustikova OS
Hum Gene Ther Methods; 2017 Aug; 28(4):191-204. PubMed ID: 28683573
[TBL] [Abstract][Full Text] [Related]
3. Transduction of Murine Hematopoietic Stem Cells with Tetracycline-regulated Lentiviral Vectors.
Stahlhut M; Schambach A; Kustikova OS
Methods Mol Biol; 2016; 1448():65-76. PubMed ID: 27317173
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Tetracycline-regulated Promoters in Lentiviral-based Vectors in Murine Transplantation Studies.
Stahlhut M; Ha TC; Morgan M; Schambach A; Kustikova OS
Curr Gene Ther; 2016; 16(4):242-248. PubMed ID: 27739375
[TBL] [Abstract][Full Text] [Related]
5. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors.
Vigna E; Cavalieri S; Ailles L; Geuna M; Loew R; Bujard H; Naldini L
Mol Ther; 2002 Mar; 5(3):252-61. PubMed ID: 11863414
[TBL] [Abstract][Full Text] [Related]
6. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
7. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
8. Dose response and clonal variability of lentiviral tetracycline-regulated vectors in murine hematopoietic cells.
Kustikova OS; Stahlhut M; Ha TC; Scherer R; Schambach A; Baum C
Exp Hematol; 2014 Jul; 42(7):505-515.e7. PubMed ID: 24674753
[TBL] [Abstract][Full Text] [Related]
9. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.
Yu X; Zhan X; D'Costa J; Tanavde VM; Ye Z; Peng T; Malehorn MT; Yang X; Civin CI; Cheng L
Mol Ther; 2003 Jun; 7(6):827-38. PubMed ID: 12788657
[TBL] [Abstract][Full Text] [Related]
11. Development of all-in-one multicistronic Tet-On lentiviral vectors for inducible co-expression of two transgenes.
Huang Y; Zhen R; Jiang M; Yang J; Yang Y; Huang Z; Lin Y
Biotechnol Appl Biochem; 2015; 62(1):48-54. PubMed ID: 24825511
[TBL] [Abstract][Full Text] [Related]
12. Development of ecdysone-regulated lentiviral vectors.
Galimi F; Saez E; Gall J; Hoong N; Cho G; Evans RM; Verma IM
Mol Ther; 2005 Jan; 11(1):142-8. PubMed ID: 15585415
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
14. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.
Ogueta SB; Yao F; Marasco WA
Mol Med; 2001 Aug; 7(8):569-79. PubMed ID: 11591893
[TBL] [Abstract][Full Text] [Related]
15. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
16. An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector.
Tian X; Wang G; Xu Y; Wang P; Chen S; Yang H; Gao F; Xu A; Cao F; Jin X; Manyande A; Tian Y
Hum Gene Ther; 2009 Feb; 20(2):113-23. PubMed ID: 20377365
[TBL] [Abstract][Full Text] [Related]
17. Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter.
Brendel C; Müller-Kuller U; Schultze-Strasser S; Stein S; Chen-Wichmann L; Krattenmacher A; Kunkel H; Dillmann A; Antoniou MN; Grez M
Gene Ther; 2012 Oct; 19(10):1018-29. PubMed ID: 22071971
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors: regulated gene expression.
Kafri T; van Praag H; Gage FH; Verma IM
Mol Ther; 2000 Jun; 1(6):516-21. PubMed ID: 10933976
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.
Unger C; Kärner E; Treschow A; Stellan B; Felldin U; Concha H; Wendel M; Hovatta O; Aints A; Ahrlund-Richter L; Dilber MS
Stem Cells; 2008 Oct; 26(10):2455-66. PubMed ID: 18617691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
